171 related articles for article (PubMed ID: 32016885)
1. Guiding Medicinal Chemistry with Fragment Molecular Orbital (FMO) Method.
Heifetz A; James T; Southey M; Bodkin MJ; Bromidge S
Methods Mol Biol; 2020; 2114():37-48. PubMed ID: 32016885
[TBL] [Abstract][Full Text] [Related]
2. Fragment Molecular Orbital Method Applied to Lead Optimization of Novel Interleukin-2 Inducible T-Cell Kinase (ITK) Inhibitors.
Heifetz A; Trani G; Aldeghi M; MacKinnon CH; McEwan PA; Brookfield FA; Chudyk EI; Bodkin M; Pei Z; Burch JD; Ortwine DF
J Med Chem; 2016 May; 59(9):4352-63. PubMed ID: 26950250
[TBL] [Abstract][Full Text] [Related]
3. Analyzing GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
Heifetz A; James T; Southey M; Morao I; Fedorov DG; Bodkin MJ; Townsend-Nicholson A
Methods Mol Biol; 2020; 2114():163-175. PubMed ID: 32016893
[TBL] [Abstract][Full Text] [Related]
4. Characterizing Protein-Protein Interactions with the Fragment Molecular Orbital Method.
Heifetz A; Sladek V; Townsend-Nicholson A; Fedorov DG
Methods Mol Biol; 2020; 2114():187-205. PubMed ID: 32016895
[TBL] [Abstract][Full Text] [Related]
5. Exploring GPCR-Ligand Interactions with the Fragment Molecular Orbital (FMO) Method.
Chudyk EI; Sarrat L; Aldeghi M; Fedorov DG; Bodkin MJ; James T; Southey M; Robinson R; Morao I; Heifetz A
Methods Mol Biol; 2018; 1705():179-195. PubMed ID: 29188563
[TBL] [Abstract][Full Text] [Related]
6. Characterising GPCR-ligand interactions using a fragment molecular orbital-based approach.
Heifetz A; James T; Southey M; Morao I; Aldeghi M; Sarrat L; Fedorov DG; Bodkin MJ; Townsend-Nicholson A
Curr Opin Struct Biol; 2019 Apr; 55():85-92. PubMed ID: 31022570
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design and synthesis of potent benzothiazole inhibitors of interleukin-2 inducible T cell kinase (ITK).
MacKinnon CH; Lau K; Burch JD; Chen Y; Dines J; Ding X; Eigenbrot C; Heifetz A; Jaochico A; Johnson A; Kraemer J; Kruger S; Krülle TM; Liimatta M; Ly J; Maghames R; Montalbetti CA; Ortwine DF; Pérez-Fuertes Y; Shia S; Stein DB; Trani G; Vaidya DG; Wang X; Bromidge SM; Wu LC; Pei Z
Bioorg Med Chem Lett; 2013 Dec; 23(23):6331-5. PubMed ID: 24138940
[TBL] [Abstract][Full Text] [Related]
8. [Applications of the Fragment Molecular Orbital Method in Drug Discovery].
Ishikawa T
Yakugaku Zasshi; 2016; 136(1):121-30. PubMed ID: 26725679
[TBL] [Abstract][Full Text] [Related]
9. Accurate Scoring in Seconds with the Fragment Molecular Orbital and Density-Functional Tight-Binding Methods.
Morao I; Heifetz A; Fedorov DG
Methods Mol Biol; 2020; 2114():143-148. PubMed ID: 32016891
[TBL] [Abstract][Full Text] [Related]
10. Protein ligand interaction analysis against new CaMKK2 inhibitors by use of X-ray crystallography and the fragment molecular orbital (FMO) method.
Takaya D; Niwa H; Mikuni J; Nakamura K; Handa N; Tanaka A; Yokoyama S; Honma T
J Mol Graph Model; 2020 Sep; 99():107599. PubMed ID: 32348940
[TBL] [Abstract][Full Text] [Related]
11. FMODB: The World's First Database of Quantum Mechanical Calculations for Biomacromolecules Based on the Fragment Molecular Orbital Method.
Takaya D; Watanabe C; Nagase S; Kamisaka K; Okiyama Y; Moriwaki H; Yuki H; Sato T; Kurita N; Yagi Y; Takagi T; Kawashita N; Takaba K; Ozawa T; Takimoto-Kamimura M; Tanaka S; Fukuzawa K; Honma T
J Chem Inf Model; 2021 Feb; 61(2):777-794. PubMed ID: 33511845
[TBL] [Abstract][Full Text] [Related]
12. Prediction of cyclin-dependent kinase 2 inhibitor potency using the fragment molecular orbital method.
Mazanetz MP; Ichihara O; Law RJ; Whittaker M
J Cheminform; 2011 Jan; 3(1):2. PubMed ID: 21219630
[TBL] [Abstract][Full Text] [Related]
13. Analyzing Interactions with the Fragment Molecular Orbital Method.
Fedorov DG
Methods Mol Biol; 2020; 2114():49-73. PubMed ID: 32016886
[TBL] [Abstract][Full Text] [Related]
14. Characterizing Rhodopsin-Arrestin Interactions with the Fragment Molecular Orbital (FMO) Method.
Heifetz A; Townsend-Nicholson A
Methods Mol Biol; 2020; 2114():177-186. PubMed ID: 32016894
[TBL] [Abstract][Full Text] [Related]
15. Hotspot Identification and Drug Design of Protein-Protein Interaction Modulators Using the Fragment Molecular Orbital Method.
Monteleone S; Fedorov DG; Townsend-Nicholson A; Southey M; Bodkin M; Heifetz A
J Chem Inf Model; 2022 Aug; 62(16):3784-3799. PubMed ID: 35939049
[TBL] [Abstract][Full Text] [Related]
16. Assessment and acceleration of binding energy calculations for protein-ligand complexes by the fragment molecular orbital method.
Otsuka T; Okimoto N; Taiji M
J Comput Chem; 2015 Nov; 36(30):2209-18. PubMed ID: 26400829
[TBL] [Abstract][Full Text] [Related]
17. Extending the power of quantum chemistry to large systems with the fragment molecular orbital method.
Fedorov DG; Kitaura K
J Phys Chem A; 2007 Aug; 111(30):6904-14. PubMed ID: 17511437
[TBL] [Abstract][Full Text] [Related]
18. GAMESS as a free quantum-mechanical platform for drug research.
Alexeev Y; Mazanetz MP; Ichihara O; Fedorov DG
Curr Top Med Chem; 2012; 12(18):2013-33. PubMed ID: 23110536
[TBL] [Abstract][Full Text] [Related]
19. Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design.
Cook BN; Bentzien J; White A; Nemoto PA; Wang J; Man CC; Soleymanzadeh F; Khine HH; Kashem MA; Kugler SZ; Wolak JP; Roth GP; De Lombaert S; Pullen SS; Takahashi H
Bioorg Med Chem Lett; 2009 Feb; 19(3):773-7. PubMed ID: 19111460
[TBL] [Abstract][Full Text] [Related]
20. Electron-correlated fragment-molecular-orbital calculations for biomolecular and nano systems.
Tanaka S; Mochizuki Y; Komeiji Y; Okiyama Y; Fukuzawa K
Phys Chem Chem Phys; 2014 Jun; 16(22):10310-44. PubMed ID: 24740821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
